Hypoxia and energetic tumour metabolism

Current Opinion in Genetics and Development

Volumn 21, Issue 1, 2011, Pages 67-72

  Brahimi Horn, M Christiane ^a   Bellot, Gregory ^a   Pouysségur, Jacques ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; CARBONATE DEHYDRATASE IX; COTRANSPORTER; GLYCOGEN; HYPOXIA INDUCIBLE FACTOR 1; LACTIC ACID; LIPID; PROTEIN MCT4; UNCLASSIFIED DRUG;

ANGIOGENESIS; AUTOPHAGY; BIOSYNTHESIS; CANCER CELL; CANCER SURVIVAL; CATABOLISM; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HUMAN; HYPOXIA; LIPID STORAGE; LIPOGENESIS; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

CELL HYPOXIA; CELL SURVIVAL; ENERGY METABOLISM; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASMS; STRESS, PHYSIOLOGICAL;

EID: 79551628206     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2010.10.006     Document Type: Review

References (44)

1. Brahimi-Horn M.C., Pouyssegur J. HIF at a glance. J Cell Sci 2009, 122:1055-1057.
2. Chiche J., Brahimi-Horn M.C., Pouyssegur J. Tumor hypoxia induces a metabolic shift causing acidosis: a common feature in cancer. J Cell Mol Med 2009.
3. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
4. Aragones J., Fraisl P., Baes M., Carmeliet P. Oxygen sensors at the crossroad of metabolism. Cell Metab 2009, 9:11-22.
5. Trastour C., Benizri E., Ettore F., Ramaioli A., Chamorey E., Pouyssegur J., Berra E. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer 2007, 120:1451-1458.
6. Semenza G.L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2009, 29:625-634.
7. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009, 9:265-273.
8. Hill R.P., Marie-Egyptienne D.T., Hedley D.W. Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol 2009, 19:106-111.
9. Pouyssegur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443.
10. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3:347-361.
11. Desiderio M.A. Hepatocyte growth factor in invasive growth of carcinomas. Cell Mol Life Sci 2007, 64:1341-1354.
12. Finger E.C., Giaccia A.J. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev 2010, 29:285-293.
13. Chung A.S., Lee J., Ferrara N. Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 2010, 10:505-514.
14. Simon M.P., Tournaire R., Pouyssegur J. The angiopoietin-2 gene of endothelial cells is upregulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J Cell Physiol 2008, 217:809-818.
15. Germain S., Monnot C., Muller L., Eichmann A. Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding. Curr Opin Hematol 2010, 17:245-251.
16. White E., Karp C., Strohecker A.M., Guo Y., Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr Opin Cell Biol 2010, 22:212-217.
17. Mazure N.M., Pouyssegur J. Hypoxia-induced autophagy: cell death or cell survival?. Curr Opin Cell Biol 2009, 22:177-180.
18. Bellot G., Garcia-Medina R., Gounon P., Chiche J., Roux D., Pouyssegur J., Mazure N.M. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009, 29:2570-2581.
19. Zhang H., Bosch-Marce M., Shimoda L.A., Tan Y.S., Baek J.H., Wesley J.B., Gonzalez F.J., Semenza G.L. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem 2008, 283:10892-10903.
20. Chiche J., Rouleau M., Gounon P., Brahimi-Horn M.C., Pouyssegur J., Mazure N.M. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli. J Cell Physiol 2010, 222:648-657.
21. Suen D.F., Norris K.L., Youle R.J. Mitochondrial dynamics and apoptosis. Genes Dev 2008, 22:1577-1590.
22. Brahimi-Horn M.C., Pouyssegur J. Oxygen, a source of life and stress. FEBS Lett 2007, 581:3582-3591.
23. Semenza G.L. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 2009, 19:12-16.
24. Fontana L., Partridge L., Longo V.D. Extending healthy life span--from yeast to humans. Science 2010, 328:321-326.
25. Zhong L., D'Urso A., Toiber D., Sebastian C., Henry R.E., Vadysirisack D.D., Guimaraes A., Marinelli B., Wikstrom J.D., Nir T., et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010, 140:280-293.
26. Dioum E.M., Chen R., Alexander M.S., Zhang Q., Hogg R.T., Gerard R.D., Garcia J.A. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 2009, 324:1289-1293.
27. Chen D., Thomas E.L., Kapahi P. HIF-1 modulates dietary restriction-mediated lifespan extension via IRE-1 in Caenorhabditis elegans. PLoS Genet 2009, 5:e1000486.
28. Mehta R., Steinkraus K.A., Sutphin G.L., Ramos F.J., Shamieh L.S., Huh A., Davis C., Chandler-Brown D., Kaeberlein M. Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science 2009, 324:1196-1198.
29. Zhang N., Fu Z., Linke S., Chicher J., Gorman J.J., Visk D., Haddad G.G., Poellinger L., Peet D.J., Powell F., et al. The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism. Cell Metab 2010, 11:364-378.
30. Chiche J., Ilc K., Laferriere J., Trottier E., Dayan F., Mazure N.M., Brahimi-Horn M.C., Pouyssegur J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009, 69:358-368.
31. Park S., Chiche J., Pouyssegur J pH control mechanisms of tumor survival and growth. J Cell Physiol 2010, (August).
32. Schneiderhan W., Scheler M., Holzmann K.H., Marx M., Gschwend J.E., Bucholz M., Gress T.M., Seufferlein T., Adler G., Oswald F. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models. Gut 2009, 58:1391-1398.
33. Pescador N., Villar D., Cifuentes D., Garcia-Rocha M., Ortiz-Barahona A., Vazquez S., Ordonez A., Cuevas Y., Saez-Morales D., Garcia-Bermejo M.L., et al. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1. PLoS One 2010, 5:e9644.
34. Krishnan J., Suter M., Windak R., Krebs T., Felley A., Montessuit C., Tokarska-Schlattner M., Aasum E., Bogdanova A., Perriard E., et al. Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab 2009, 9:512-524.
35. Rankin E.B., Rha J., Selak M.A., Unger T.L., Keith B., Liu Q., Haase V.H. Hypoxia-inducible factor 2 regulates hepatic lipid metabolism. Mol Cell Biol 2009, 29:4527-4538.
36. Gimm T., Wiese M., Teschemacher B., Deggerich A., Schodel J., Knaup K.X., Hackenbeck T., Hellerbrand C., Amann K., Wiesener M.S., et al. Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1. Faseb J 2010.
37. Fogarty S., Hardie D.G. Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 2010, 1804:581-591.
38. McBride A., Hardie D.G. AMP-activated protein kinase--a sensor of glycogen as well as AMP and ATP?. Acta Physiol (Oxf) 2009, 196:99-113.
39. Brugarolas J., Lei K., Hurley R.L., Manning B.D., Reiling J.H., Hafen E., Witters L.A., Ellisen L.W., Kaelin W.G. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004, 18:2893-2904.
40. Kaelin W.G. The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 2008, 8:865-873.
41. Fantin V.R., St-Pierre J., Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 2006, 9:425-434.
42. Pelicano H., Martin D.S., Xu R.H., Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25:4633-4646.
43. Sreekumar A., Poisson L.M., Rajendiran T.M., Khan A.P., Cao Q., Yu J., Laxman B., Mehra R., Lonigro R.J., Li Y., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009, 457:910-914.
44. Morrish F., Isern N., Sadilek M., Jeffrey M., Hockenbery D.M. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene 2009, 28:2485-2491.